Takeover

ABSIAbsci Corp

Services-Commercial Physical & Biological Research

Revenue
$3MFY2021: $4MFY2022: $5MFY2023: $6MFY2024: $5MFY2025: $3M
38% YoY
Operating margin
-4297.0%FY2021: -1876.7%FY2022: -2357.0%FY2023: -2020.2%FY2024: -2401.6%FY2025: -4297.0%
79% YoY
EBITDA
−$109MFY2021: −$69MFY2022: −$94MFY2023: −$102MFY2024: −$95MFY2025: −$109M
14% YoY
Market cap
$1.3B
Employees
140
$20K revenue each
Net debt / EBITDA
—
−$104M net debt
AI in 10-K
13.7
mentions per 10K words

Takeover score 4 of 13

Fixable underperformance 2 of 7

Buyer economics 2 of 4

Catalysts 0 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$4M$5M$6M$5M$3M 38% FY2021: $4MFY2022: $5MFY2023: $6MFY2024: $5MFY2025: $3M
Operating income−$75M−$107M−$116M−$109M−$120M 10% FY2021: −$75MFY2022: −$107MFY2023: −$116MFY2024: −$109MFY2025: −$120M
Net income−$101M−$105M−$111M−$103M−$115M 12% FY2021: −$101MFY2022: −$105MFY2023: −$111MFY2024: −$103MFY2025: −$115M
Operating cash flow−$61M−$81M−$65M−$72M−$93M 28% FY2021: −$61MFY2022: −$81MFY2023: −$65MFY2024: −$72MFY2025: −$93M
Capex$38M$16M$860K$404K$1M 174% FY2021: $38MFY2022: $16MFY2023: $860KFY2024: $404KFY2025: $1M
Stock-based comp$11M$13M$11M$19M$18M 5.8% FY2021: $11MFY2022: $13MFY2023: $11MFY2024: $19MFY2025: $18M

Deal filings

None.

13D filers

FiledFilerFormStakeIntent
Apr 14, 2026Redmile Group, LLCSCHEDULE 13D/A4.9%Passive
Mar 26, 2026Redmile Group, LLCSCHEDULE 13D/A5.4%Passive
Apr 29, 2025Redmile Group, LLCSCHEDULE 13D/A6.5%Passive
Mar 5, 2024Redmile Group, LLCSC 13D/A7.4%Passive
May 8, 2023Casdin Capital, LLCSC 13D/A4.8%Passive
Mar 20, 2023Casdin Capital, LLCSC 13D/A6.0%Passive
Feb 13, 2023Casdin Capital, LLCSC 13D/A7.0%Passive
Jul 21, 2022Casdin Capital, LLCSC 13D/A8.3%Passive
Aug 2, 2021Redmile Group, LLCSC 13D8.7%Passive
Jul 29, 2021Casdin Capital, LLCSC 13D8.5%Passive

Insider trading

Open-market buys, 12 mo
$933K · 5
Open-market sells, 12 mo
$132K · 2
Net
$801K

Pay vs performance

No pay-versus-performance disclosure yet.